
Tissue Regenix Group Investor Relations Material
Latest events

H2 2024
Tissue Regenix Group
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tissue Regenix Group plc
Access all reports
Tissue Regenix Group plc is a UK-based regenerative medical devices company. It develops and commercializes biological implants and tissue-based products for use in orthopedics, wound care, and dental applications. Its patented decellularization technology processes human and animal tissue for safe and effective transplant use. The company is headquartered in Leeds, United Kingdom, and its shares are listed on the LSE.
Key slides for Tissue Regenix Group plc


H2 2024
Tissue Regenix Group plc


H2 2024
Tissue Regenix Group plc
Latest articles
Ticker symbol
TRX
Country
🇬🇧 United Kingdom